Jenessa N Johnston

6PUBLICATIONS
14CO-AUTHORS
Biologically active moleculesPharmaceutical delivery technologiesComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)PharmacogenomicsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.

|Jul 24, 2026
Time-dependent effects of rapid-acting antidepressants in iPSC-derived neurons from treatment-resistant depression and healthy volunteers.

|Nov 19, 2025
Response of iPSC-derived neurons from individuals with treatment-resistant depression to (2 R,6 R)-hydroxynorketamine and reelin: an exploratory study.

Jenessa N Johnston, Peixiong Yuan, Bashkim Kadriu

|Jul 12, 2024
Esketamine in depression: putative biomarkers from clinical research.

Jenessa N Johnston, Carlos A Zarate, Mark D Kvarta

|Aug 07, 2023
Reelin Rescues Behavioral, Electrophysiological, and Molecular Metrics of a Chronic Stress Phenotype in a Similar Manner to Ketamine.

Jenessa N Johnston, Josh Allen, Irene Shkolnikov

|Jun 20, 2023
Ketamine in neuropsychiatric disorders: an update.

Jenessa N Johnston, Bashkim Kadriu, Christoph Kraus

Pageof 1

Frequent Collaborators

4 joint publications

Bashkim Kadriu

3 joint publications

Mark D Kvarta

3 joint publications

Anton Schulmann

3 joint publications

Francis J McMahon